BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval
Go back to BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval| AbbVie (NYSE: ABBV) | Delayed: 256.97 -1.18 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $258.15 | 52 Week High | $68.12 | |||
| Open | $258.67 | 52 Week Low | $50.71 | |||
| Day High | $259.00 | P/E | 55.74 | |||
| Day Low | $256.00 | EPS | $4.61 | |||
| Volume | 601,263 | |||||
